Results 81 to 90 of about 1,688,218 (301)

MR Imaging of Peripheral Nerves Using Targeted Application of Contrast Agents: An Experimental Proof-of-Concept Study

open access: yesFrontiers in Medicine, 2020
Introduction: Current imaging modalities for peripheral nerves display the nerve's structure but not its function. Based on a nerve's capacity for axonal transport, it may be visualized by targeted application of a contrast agent and assessing the ...
Vlad Tereshenko   +23 more
doaj   +1 more source

Neutral 1,3-Diindolylureas for nerve agent remediation

open access: yes, 2012
Efficient neutralization of nerve?agent simulants by 1,3?diindolylureas in a neutral medium was investigated (see scheme; DCP=diethylchlorophosphate, DCNP=diethylcyanophosphonate).
Costero Nieto, Ana María   +18 more
core   +1 more source

Malformin A1–mediated cytotoxicity in ovarian cancer cells occurs through pyroptosis and autophagy

open access: yesFEBS Open Bio, EarlyView.
This study investigated the effects of the natural compound Malformin A1 (MA1) on the cytoskeleton that regulates cell proliferation and migration. Disruption of the cytoskeleton can impair these processes and promote cancer cell death. MA1 disrupted cytoskeletal organization, induced DNA damage, inflammation, activated autophagy, and pyroptosis ...
Nada Abdullah Hassan   +11 more
wiley   +1 more source

Nerve-terminal and Schwann-cell response after nerve injury in the absence of nitric oxide

open access: yes, 2015
Dystrophic muscles show alterations in the dystrophin-glycoprotein complex and a lack of neuronal nitric oxide (NO) synthase. In mdx mice, presynaptic expression of neuronal NO synthase is decreased, suggesting that presynaptic signaling may be altered ...
Santo, H   +3 more
core   +2 more sources

GelMA‐based 3D spheroids recapitulate transcriptomic and functional hallmarks of myeloid sarcoma

open access: yesFEBS Open Bio, EarlyView.
GelMA 5% hydrogels support the formation of myeloid leukemia spheroids that recapitulate MS‐specific features, including G1 arrest, apoptosis, and ECM‐driven transcriptomic reprogramming. The 3D model mimicked soft‐tissue‐like stiffness and oxygen conditions, and transcriptomic convergence with primary MS samples confirmed its utility as a preclinical ...
Nicolas Germain   +11 more
wiley   +1 more source

Investigation into the pharmacodynamics of ethanol as a nerve blocking agent

open access: yes, 2014
Ethanol is a known nerve-blocking agent, yet its clinical use is minimal. This is partly due to unclear dosage levels and not enough knowledge of its pharmacodynamics and overwhelming dominance of its psychomotor properties.
Maibvise, Charles
core  

Characterization of the key membrane protein cytochrome Cyc2 from Ghiorsea bivora

open access: yesFEBS Open Bio, EarlyView.
This study reports the first detailed biochemical analysis of Cyc2TAG1_1, a cytochrome protein involved in microbial iron oxidation. We produced and purified this enzyme in E. coli, then measured its iron‐oxidizing efficiency, and characterized its electrical and structural properties.
Josiane Azizi   +6 more
wiley   +1 more source

SAW Chemical Array Device Coated with Polymeric Sensing Materials for the Detection of Nerve Agents

open access: yesSensors, 2020
G nerve agents are colorless, odorless, and lethal chemical warfare agents (CWAs). The threat of CWAs, which cause critical damage to humans, continues to exist, e.g., in warfare or terrorist attacks. Therefore, it is important to be able to detect these
Jinuk Kim   +4 more
doaj   +1 more source

Investigation into the pharmacodynamics of ethanol as a nerve blocking agent

open access: yes, 2019
Ethanol is a known nerve-blocking agent, yet its clinical use is minimal. This is partly due to unclear dosage levels and not enough knowledge of its pharmacodynamics and overwhelming dominance of its psychomotor properties.
Maibvise, Charles
core  

High-throughput screening of solid-state catalysts for nerve agent degradation

open access: yes, 2018
A high-throughput screening (HTS) method was devised to increase the rate of discovery and evaluation of nerve agent degradation catalysts.
Gregory W. Peterson   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy